Presence of anti-cyclic citrullinated peptide antibodies is associated with better treatment response to abatacept but not to TNF inhibitors in patients with rheumatoid arthritis: a meta-analysis
ContributorsAlemao, Evo; Postema, Roelien; Elbez, Yedid; Mamane, Carole; Finckh, Axel
Published inClinical and Experimental Rheumatology
Publication date2019
Abstract
Keywords
- Anti-cyclic citrullinated peptide antibodies
- Biomarker
- Abatacept
- TNF inhibitors
- Rheumatoid arthritis
Affiliation
Research group
Citation (ISO format)
ALEMAO, Evo et al. Presence of anti-cyclic citrullinated peptide antibodies is associated with better treatment response to abatacept but not to TNF inhibitors in patients with rheumatoid arthritis: a meta-analysis. In: Clinical and Experimental Rheumatology, 2019.
